New scan may reveal hidden Alzheimer's in stroke survivors

NCT ID NCT02813434

Completed Diagnosis Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special PET scan using florbetapir can help doctors figure out why some people develop memory and thinking problems after a stroke. The scan looks for amyloid plaques, a hallmark of Alzheimer's disease. Researchers studied 92 adults aged 40 to 80 who had a stroke and later experienced cognitive issues. The goal was to see how often Alzheimer's might be the underlying cause, which could guide better diagnosis and care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: florbetapir (a radioactive tracer for PET scans)
What this could lead to: If successful, this could help doctors better identify whether Alzheimer's disease is causing cognitive decline after a stroke, leading to more targeted care.
What could go wrong: This is a completed Phase 3 study with 92 participants, so results are available but may not apply to all stroke survivors. The scan is for diagnosis only, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITION DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognition Disorders cognitive disorder dementia vascular dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITION DISORDERS DEMENTIA

Contacts and locations

Locations

CHU Amiens

Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.